Ernexa Therapeutics ERNA
NASDAQ ERNA
$2.96 -0.24 (-7.50%)
At close: Oct 1, 2026 · 4:00 PM EDT

Ernexa Therapeutics (ERNA) Goodwill impairment charges (2020 - 2026)

Updated

Ernexa Therapeutics (ERNA) posted Goodwill impairment charges of $2.04 million for Q1 2026.

Analysis

Ernexa Therapeutics (ERNA) Goodwill impairment charges (2020 - 2026) Analysis & Trends

For FY2020, Ernexa Therapeutics' Goodwill impairment charges came in at $662,000.

  • In prior years, Ernexa Therapeutics' Goodwill impairment charges was $261,000 in FY2018.
  • The Q1 2026 figure stands as the lowest quarterly Goodwill impairment charges since Q1 2020.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn
10 Ernexa Therapeutics 3.74 Mn 3.74 Mn -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 2.04 Mn
Mar 31, 2020 662,000.00
API Access

Ernexa Therapeutics Goodwill impairment charges API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=goodwill-impairment-charges&ticker=ERNA&period=max&api_key=YOUR_API_KEY